tiprankstipranks
VentriPoint Diagnostics Ltd (TSE:VPT)
TSXV:VPT

VentriPoint Diagnostics (VPT) Stock Price & Analysis

21 Followers

VPT Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.12 - C$0.36
Previous CloseC$0.23
Volume42.90K
Average Volume (3M)103.63K
Market Cap
C$35.37M
Enterprise ValueC$33.49M
Total Cash (Recent Filing)C$2.30M
Total Debt (Recent Filing)C$428.57K
Price to Earnings (P/E)-7.5
Beta0.43
Apr 29, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding156,823,905
10 Day Avg. Volume61,409
30 Day Avg. Volume103,628
Standard Deviation0.36
R-Squared0.00435
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)27.45
Price to Sales (P/S)518.82
Price to Cash Flow (P/CF)-9.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

14.81%0.00%0.00%85.19%
14.81%
Insiders
0.00% Other Institutional Investors
85.19% Public Companies and
Individual Investors

VPT FAQ

What was VentriPoint Diagnostics Ltd’s price range in the past 12 months?
VentriPoint Diagnostics Ltd lowest stock price was C$0.12 and its highest was C$0.36 in the past 12 months.
    What is VentriPoint Diagnostics Ltd’s market cap?
    Currently, no data Available
    When is VentriPoint Diagnostics Ltd’s upcoming earnings report date?
    VentriPoint Diagnostics Ltd’s upcoming earnings report date is Apr 29, 2024 which is in 10 days.
      How were VentriPoint Diagnostics Ltd’s earnings last quarter?
      VentriPoint Diagnostics Ltd released its earnings results on Nov 29, 2023. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
        Is VentriPoint Diagnostics Ltd overvalued?
        According to Wall Street analysts VentriPoint Diagnostics Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does VentriPoint Diagnostics Ltd pay dividends?
          VentriPoint Diagnostics Ltd does not currently pay dividends.
          What is VentriPoint Diagnostics Ltd’s EPS estimate?
          VentriPoint Diagnostics Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does VentriPoint Diagnostics Ltd have?
          VentriPoint Diagnostics Ltd has 157,182,650 shares outstanding.
            What happened to VentriPoint Diagnostics Ltd’s price movement after its last earnings report?
            VentriPoint Diagnostics Ltd reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of VentriPoint Diagnostics Ltd?
              Currently, no hedge funds are holding shares in TSE:VPT
              ---

              VentriPoint Diagnostics Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              9.75%
              12-Months-Change

              Fundamentals

              Return on Equity
              -141.63%
              Trailing 12-Months
              Asset Growth
              -55.43%
              Trailing 12-Months

              Company Description

              VentriPoint Diagnostics Ltd

              VentriPoint Diagnostics Ltd is a Canada based medical device company. It is primarily engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure and normal hearts. It sells its products in Canada and internationally.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Vitalhub
              Medmira
              Tetra Bio-Pharma
              Ondine Biomedical, Inc.
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis